Zymeworks Inc. (NYSE: ZYME) Files An 8-K Entry into a Material Definitive Agreement

Zymeworks Inc. (NYSE: ZYME) Files An 8-K Entry into a Material Definitive Agreement
Item 1.01

Story continues below


Zymeworks Inc. Exhibit
EX-99.1 2 d596335dex991.htm EX-99.1 EX-99.1 Exhibit 99.1      Zymeworks and BeiGene Announce License and Collaboration Agreement for Zymeworks’ HER2-Targeted Therapeutic Candidates,…
To view the full exhibit click here

An ad to help with our costs